Orion Pharma Limited Share Price

Equities

ORIONPHARM

BD0486OPL004

Pharmaceuticals

End-of-day quote Dhaka S.E. 03:30:00 25/04/2024 am IST 5-day change 1st Jan Change
62.8 BDT -2.94% Intraday chart for Orion Pharma Limited -4.41% -21.11%

Financials

Sales 2022 9.66B 87.85M 7.32B Sales 2023 13.93B 127M 10.56B Capitalization 18.63B 169M 14.12B
Net income 2022 846M 7.69M 641M Net income 2023 641M 5.83M 486M EV / Sales 2022 4.04 x
Net Debt 2022 18.45B 168M 13.98B Net Debt 2023 21.7B 197M 16.45B EV / Sales 2023 2.9 x
P/E ratio 2022
24.3 x
P/E ratio 2023
29.1 x
Employees 2,716
Yield 2022
1.14%
Yield 2023
1.26%
Free-Float 68.02%
More Fundamentals * Assessed data
Dynamic Chart
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Orion Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Orion Pharma Limited Recommends Cash Dividend for the Year Ended June 30, 2022 CI
Orion Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
Orion Pharma Limited Recommends Cash Divided for the Year Ended on June 30, 2020 CI
Orion Pharma Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020 CI
Orion Pharma Limited Appoints Zareen Karim as Managing Director CI
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019 CI
Orion Pharma Limited Recommends Cash Dividend for the Year Ended on June 30, 2019 CI
More news
1 day-2.94%
1 week-4.41%
Current month-11.92%
1 month-6.13%
3 months-21.11%
6 months-21.11%
Current year-21.11%
More quotes
1 week
62.80
Extreme 62.8
67.00
1 month
62.80
Extreme 62.8
72.20
Current year
62.80
Extreme 62.8
91.80
1 year
62.80
Extreme 62.8
91.80
3 years
46.50
Extreme 46.5
156.50
5 years
25.20
Extreme 25.2
156.50
10 years
25.20
Extreme 25.2
156.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 01/10/01
Director of Finance/CFO - -
Compliance Officer - -
Members of the board TitleAgeSince
Chairman 69 -
Director/Board Member 68 01/85/01
Director/Board Member 42 01/10/01
More insiders
Date Price Change Volume
25/24/25 62.8 -2.94% 687,611
24/24/24 64.7 0.00% 857,342
23/24/23 64.7 -1.37% 735,632
22/24/22 65.6 +1.86% 500,973
21/24/21 64.4 -1.98% 749,534

End-of-day quote Dhaka S.E., April 25, 2024

More quotes
Orion Pharma Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health- related consumer products. The Company's products include Ambronil, Angimet MR, Arovent, Axet, Avison, Azalid, Angimet, Alve, Anvert, Baclon, Betacal, Bisoloc, Bonec, Broket, Bromazep, Boncare, Sefin, Stimulin, Silvage, ROVEX, Rupenta, Rispa, Riz, Rivo, Procap, Pep Plus, Pep, Pedicon, Pedicef, Oranex Capsule, Orsal Syrup, Orsal, Ortac, Ormin, Orlev, Orioplex, Oriodox, Orfenac, Onium, Onasia, Oclazid, Novoxen, Novodol Tablet, Nidazyl, Nervex, NOVELTA, Nosedex, Noak, Newage, Neulyn, Nugesic, Losan-D, Losan D, Losan, Lopres, Lipex, GoldKid, Goldage, Glory, Ezylax Syrup, Eroflam, Exor, Eprel, ESP, Enliven, EC PLUS, EC, Deslor Plus, Deslor, Deconil, Cosy, Co-Axet, Cloramin Syrup, Cefditor, Conaz, Combivit, Clognil Plus, Clognil and CCB.
More about the company
  1. Stock Market
  2. Equities
  3. ORIONPHARM Stock